Pfizer Inc (MIL:1PFE)
€ 24.625 -0.215 (-0.87%) Market Cap: 139.23 Bil Enterprise Value: 192.39 Bil PE Ratio: 35.39 PB Ratio: 1.61 GF Score: 64/100

Pfizer Inc Analyst And Investor Call To Review Data Presentations At Scientific Conferences During The Week Of June 15th Transcript

Jun 18, 2020 / 03:30PM GMT

Jun 18, 2020 / 03:30PM GMT
Presentations At Scientific Conferences During The Week Of June 15th
Jun 18, 2020 / 03:30PM GMT

=====================
Corporate Participants
=====================
* Aditi Saxena
Pfizer Inc. - Senior Director and Clinical Lead, Internal Medicine
* Brenda Cooperstone
Pfizer Inc. - Chief Development Officer of Rare Disease
* Charles E. Triano
Pfizer Inc. - SVP of IR
* Mikael Dolsten
Pfizer Inc. - Chief Scientific Officer and President of Worldwide Research, Development & Medical
* Morris J. Birnbaum
Pfizer Inc. - Senior VP & Chief Scientific Officer of Internal Medicine
* Seng Cheng
Pfizer Inc. - Senior VP & Chief Scientific Officer of Rare Disease Research Unit

=====================
Conference Call Participants
=====================
* David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot